| neural tube formation | GO:0001841 | 108 | 0.814 | |
| neural crest cell migration involved in autonomic nervous system development | GO:1901166 | 5 | 0.793 | |
| regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry | GO:1900094 | 2 | 0.743 | |
| transforming growth factor beta receptor signaling pathway involved in primitive streak formation | GO:0090010 | 1 | 0.670 | |
| positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process | GO:2000763 | 1 | 0.660 | |
| regionalization | GO:0003002 | 337 | 0.654 | |
| stem cell differentiation | GO:0048863 | 268 | 0.591 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.571 | |
| heart morphogenesis | GO:0003007 | 178 | 0.566 | |
| skeletal system development | GO:0001501 | 356 | 0.549 | |
| chemotaxis | GO:0006935 | 247 | 0.543 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.527 | |
| tendon formation | GO:0035992 | 4 | 0.496 | |
| nodal signaling pathway involved in determination of left right asymmetry | GO:0038107 | 2 | 0.495 | |
| hindbrain tangential cell migration | GO:0021934 | 2 | 0.473 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.465 | |
| amine metabolic process | GO:0009308 | 45 | 0.453 | |
| nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry | GO:1900164 | 2 | 0.437 | |
| mesenchyme development | GO:0060485 | 152 | 0.420 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.410 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.387 | |
| hemangioblast cell differentiation | GO:0060217 | 1 | 0.355 | |
| regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:0072039 | 4 | 0.354 | |
| auditory receptor cell fate determination | GO:0042668 | 3 | 0.354 | |
| sinoatrial node cell differentiation | GO:0060921 | 3 | 0.344 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.343 | |
| axonogenesis | GO:0007409 | 274 | 0.342 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.342 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.338 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.318 | |
| cell adhesion | GO:0007155 | 329 | 0.304 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.303 | |
| endocardial cell differentiation | GO:0060956 | 4 | 0.285 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.284 | |
| cellular response to lipid | GO:0071396 | 145 | 0.282 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.279 | |
| positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation | GO:0003257 | 3 | 0.279 | |
| telencephalon development | GO:0021537 | 186 | 0.277 | |
| tendon cell differentiation | GO:0035990 | 4 | 0.271 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.271 | |
| regulation of smoothened signaling pathway | GO:0008589 | 58 | 0.261 | |
| positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000802 | 1 | 0.252 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.248 | |
| respiratory tube development | GO:0030323 | 167 | 0.247 | |
| neural crest cell development | GO:0014032 | 48 | 0.247 | |
| stem cell development | GO:0048864 | 219 | 0.245 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.241 | |
| vagus nerve development | GO:0021564 | 3 | 0.240 | |
| carbon catabolite repression of transcription from rna polymerase ii promoter | GO:0000437 | 1 | 0.239 | |
| digestive system development | GO:0055123 | 200 | 0.235 | |
| tube formation | GO:0035148 | 140 | 0.230 | |
| metanephric capsule specification | GO:0072267 | 1 | 0.230 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.229 | |
| neuron projection guidance | GO:0097485 | 141 | 0.222 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.221 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.220 | |
| neural tube closure | GO:0001843 | 90 | 0.217 | |
| somitogenesis | GO:0001756 | 69 | 0.216 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.216 | |
| cardiac right ventricle formation | GO:0003219 | 3 | 0.215 | |
| cell maturation | GO:0048469 | 127 | 0.212 | |
| cerebellar granule cell precursor proliferation | GO:0021930 | 10 | 0.206 | |
| negative regulation of cardiac chamber morphogenesis | GO:1901220 | 2 | 0.204 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.203 | |
| embryonic heart tube formation | GO:0003144 | 1 | 0.203 | |
| cell proliferation in external granule layer | GO:0021924 | 10 | 0.203 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.202 | |
| cell proliferation in hindbrain | GO:0021534 | 10 | 0.200 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.197 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.194 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.191 | |
| stem cell maintenance | GO:0019827 | 130 | 0.189 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.187 | |
| mesodermal to mesenchymal transition involved in gastrulation | GO:0060809 | 1 | 0.186 | |
| stem cell proliferation | GO:0072089 | 117 | 0.184 | |
| lung development | GO:0030324 | 164 | 0.184 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.183 | |
| mammary placode formation | GO:0060596 | 4 | 0.182 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.180 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.179 | |
| neural crest formation | GO:0014029 | 2 | 0.177 | |
| gland development | GO:0048732 | 330 | 0.173 | |
| axial mesoderm formation | GO:0048320 | 3 | 0.173 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.170 | |
| positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus | GO:1901522 | 7 | 0.170 | |
| regulation of glial cell differentiation | GO:0045685 | 41 | 0.168 | |
| striated muscle cell development | GO:0055002 | 125 | 0.166 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.166 | |
| developmental maturation | GO:0021700 | 193 | 0.163 | |
| positive regulation of auditory receptor cell differentiation | GO:0045609 | 1 | 0.157 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.156 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.154 | |
| primary neural tube formation | GO:0014020 | 95 | 0.151 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.148 | |
| digestive tract development | GO:0048565 | 190 | 0.147 | |
| dorsal ventral neural tube patterning | GO:0021904 | 28 | 0.147 | |
| regulation of endodermal cell fate specification | GO:0042663 | 2 | 0.146 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.145 | |
| forebrain development | GO:0030900 | 302 | 0.145 | |
| axon guidance | GO:0007411 | 141 | 0.144 | |
| spinal cord motor neuron differentiation | GO:0021522 | 35 | 0.142 | |
| melanocyte differentiation | GO:0030318 | 25 | 0.140 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.140 | |
| epithelial tube formation | GO:0072175 | 130 | 0.139 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.137 | |
| gastrulation | GO:0007369 | 116 | 0.137 | |
| cerebral cortex neuron differentiation | GO:0021895 | 19 | 0.136 | |
| limb development | GO:0060173 | 166 | 0.135 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.134 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.130 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.129 | |
| somite development | GO:0061053 | 81 | 0.129 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.129 | |
| smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation | GO:0021938 | 4 | 0.129 | |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.127 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.127 | |
| regulation of secretion | GO:0051046 | 274 | 0.126 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.126 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.125 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.125 | |
| striated muscle cell proliferation | GO:0014855 | 39 | 0.125 | |
| response to growth factor | GO:0070848 | 198 | 0.124 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.124 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.124 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.124 | |
| cardiac left ventricle formation | GO:0003218 | 1 | 0.123 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.122 | |
| regulation of skeletal muscle fiber differentiation | GO:1902809 | 3 | 0.122 | |
| regulation of transcription from rna polymerase ii promoter involved in forebrain neuron fate commitment | GO:0021882 | 3 | 0.121 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.120 | |
| cellular response to cholesterol | GO:0071397 | 2 | 0.120 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.120 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.119 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.119 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.119 | |
| mapk cascade | GO:0000165 | 281 | 0.118 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.118 | |
| positive regulation of inner ear receptor cell differentiation | GO:2000982 | 1 | 0.118 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.116 | |
| noradrenergic neuron development | GO:0003358 | 3 | 0.114 | |
| axial mesodermal cell fate commitment | GO:0048322 | 1 | 0.113 | |
| cell proliferation involved in kidney development | GO:0072111 | 14 | 0.112 | |
| oocyte axis specification | GO:0007309 | 2 | 0.111 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.110 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.109 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.109 | |
| cytokine production | GO:0001816 | 319 | 0.109 | |
| negative regulation of gastrulation | GO:2000542 | 3 | 0.108 | |
| muscle tissue development | GO:0060537 | 308 | 0.108 | |
| positive regulation of transcription from rna polymerase ii promoter involved in heart development | GO:1901228 | 4 | 0.107 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.107 | |
| regulation of neuron maturation | GO:0014041 | 5 | 0.106 | |
| cerebral cortex gabaergic interneuron fate commitment | GO:0021893 | 2 | 0.105 | |
| cardiac epithelial to mesenchymal transition | GO:0060317 | 18 | 0.105 | |
| his purkinje system cell differentiation | GO:0060932 | 2 | 0.104 | |
| apoptotic process involved in outflow tract morphogenesis | GO:0003275 | 2 | 0.104 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.103 | |
| locus ceruleus development | GO:0021703 | 1 | 0.103 | |
| neural crest cell differentiation | GO:0014033 | 54 | 0.103 | |
| hindlimb morphogenesis | GO:0035137 | 42 | 0.102 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.101 | |
| bone development | GO:0060348 | 120 | 0.101 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.099 | |
| otolith morphogenesis | GO:0032474 | 3 | 0.098 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.098 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.097 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.097 | |
| positive regulation of skeletal muscle cell differentiation | GO:2001016 | 4 | 0.096 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.096 | |
| negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:0072040 | 4 | 0.095 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.094 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.094 | |
| bone morphogenesis | GO:0060349 | 78 | 0.094 | |
| positive regulation of neuroblast proliferation | GO:0002052 | 19 | 0.093 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.093 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.092 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.090 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.090 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.090 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.090 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.090 | |
| connective tissue development | GO:0061448 | 179 | 0.090 | |
| ear development | GO:0043583 | 200 | 0.090 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.089 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.089 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.089 | |
| tube closure | GO:0060606 | 91 | 0.089 | |
| positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090100 | 43 | 0.088 | |
| negative regulation of epidermis development | GO:0045683 | 9 | 0.088 | |
| negative regulation of stem cell maintenance | GO:1902455 | 4 | 0.088 | |
| olfactory lobe development | GO:0021988 | 32 | 0.087 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.086 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.086 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.085 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.084 | |
| hindbrain development | GO:0030902 | 128 | 0.084 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.084 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.083 | |
| regulation of tongue muscle cell differentiation | GO:2001035 | 2 | 0.083 | |
| globus pallidus development | GO:0021759 | 2 | 0.083 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.081 | |
| muscle cell development | GO:0055001 | 133 | 0.080 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.080 | |
| embryonic nail plate morphogenesis | GO:0035880 | 3 | 0.080 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.079 | |
| regulation of mast cell differentiation | GO:0060375 | 3 | 0.079 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.078 | |
| embryonic camera type eye development | GO:0031076 | 36 | 0.078 | |
| aorta morphogenesis | GO:0035909 | 22 | 0.078 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 33 | 0.078 | |
| positive regulation of tendon cell differentiation | GO:2001051 | 1 | 0.077 | |
| forebrain neuron fate commitment | GO:0021877 | 13 | 0.077 | |
| trophectodermal cellular morphogenesis | GO:0001831 | 3 | 0.077 | |
| regulation of male germ cell proliferation | GO:2000254 | 3 | 0.076 | |
| positive regulation of skeletal muscle fiber differentiation | GO:1902811 | 2 | 0.075 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.075 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.075 | |
| spermatogenesis | GO:0007283 | 284 | 0.075 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.074 | |
| angiogenesis | GO:0001525 | 201 | 0.073 | |
| response to oxygen levels | GO:0070482 | 62 | 0.073 | |
| microtubule based process | GO:0007017 | 236 | 0.073 | |
| epithelial cell development | GO:0002064 | 159 | 0.072 | |
| ventricular septum morphogenesis | GO:0060412 | 27 | 0.072 | |
| pyramidal neuron migration | GO:0021852 | 1 | 0.072 | |
| heart field specification | GO:0003128 | 6 | 0.072 | |
| biomineral tissue development | GO:0031214 | 64 | 0.072 | |
| regulation of mesenchymal cell proliferation involved in ureter development | GO:0072199 | 3 | 0.071 | |
| astrocyte activation | GO:0048143 | 2 | 0.071 | |
| lateral line system development | GO:0048925 | 1 | 0.071 | |
| trachea formation | GO:0060440 | 3 | 0.070 | |
| nephrogenic mesenchyme development | GO:0072076 | 3 | 0.070 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.070 | |
| histone acetylation | GO:0016573 | 41 | 0.069 | |
| positive regulation of non canonical wnt signaling pathway | GO:2000052 | 6 | 0.069 | |
| negative regulation of cell maturation | GO:1903430 | 9 | 0.069 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.069 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.069 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.069 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.068 | |
| chromatin modification | GO:0016568 | 187 | 0.068 | |
| negative regulation of canonical wnt signaling pathway involved in neural plate anterior posterior pattern formation | GO:0060829 | 1 | 0.068 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.067 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.067 | |
| positive regulation of glial cell differentiation | GO:0045687 | 21 | 0.067 | |
| response to oxidative stress | GO:0006979 | 123 | 0.067 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.066 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.066 | |
| response to amino acid | GO:0043200 | 37 | 0.066 | |
| embryonic skeletal joint morphogenesis | GO:0060272 | 11 | 0.065 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.065 | |
| midgut development | GO:0007494 | 4 | 0.064 | |
| positive regulation of cardioblast differentiation | GO:0051891 | 3 | 0.064 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.064 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.063 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.063 | |
| embryonic placenta development | GO:0001892 | 98 | 0.063 | |
| epithelial cell maturation involved in prostate gland development | GO:0060743 | 4 | 0.062 | |
| frontal suture morphogenesis | GO:0060364 | 2 | 0.062 | |
| t cell activation | GO:0042110 | 289 | 0.062 | |
| positive regulation of tongue muscle cell differentiation | GO:2001037 | 2 | 0.061 | |
| cardioblast differentiation | GO:0010002 | 13 | 0.061 | |
| triglyceride homeostasis | GO:0070328 | 15 | 0.061 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.061 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.061 | |
| neural crest cell fate commitment | GO:0014034 | 1 | 0.060 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.060 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.060 | |
| negative regulation of photoreceptor cell differentiation | GO:0046533 | 4 | 0.060 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.059 | |
| mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:1901145 | 4 | 0.059 | |
| oligodendrocyte development | GO:0014003 | 20 | 0.059 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.059 | |
| cerebellum development | GO:0021549 | 77 | 0.058 | |
| specification of organ identity | GO:0010092 | 30 | 0.058 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.057 | |
| regulation of gliogenesis | GO:0014013 | 50 | 0.057 | |
| otic placode formation | GO:0043049 | 1 | 0.057 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.057 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.057 | |
| oocyte construction | GO:0007308 | 2 | 0.057 | |
| negative regulation of smoothened signaling pathway | GO:0045879 | 25 | 0.056 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.056 | |
| cardiac chamber formation | GO:0003207 | 10 | 0.056 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.056 | |
| regulation of vascular wound healing | GO:0061043 | 2 | 0.056 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.055 | |
| negative regulation of cell fate specification | GO:0009996 | 4 | 0.055 | |
| regulation of cardiac muscle tissue growth | GO:0055021 | 26 | 0.055 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.055 | |
| brain morphogenesis | GO:0048854 | 32 | 0.055 | |
| male meiosis | GO:0007140 | 37 | 0.055 | |
| positive regulation of wnt signaling pathway | GO:0030177 | 45 | 0.055 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.055 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.054 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.054 | |
| regulation of cell maturation | GO:1903429 | 13 | 0.054 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.053 | |
| cell proliferation involved in metanephros development | GO:0072203 | 9 | 0.053 | |
| cardiogenic plate morphogenesis | GO:0003142 | 1 | 0.053 | |
| maintenance of location | GO:0051235 | 89 | 0.053 | |
| mesenchymal cell proliferation | GO:0010463 | 44 | 0.053 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.053 | |
| mesoderm development | GO:0007498 | 100 | 0.053 | |
| somite specification | GO:0001757 | 4 | 0.052 | |
| muscle system process | GO:0003012 | 141 | 0.052 | |
| vascular wound healing | GO:0061042 | 3 | 0.052 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.052 | |
| endomembrane system organization | GO:0010256 | 147 | 0.052 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.052 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.052 | |
| cardiac neural crest cell migration involved in outflow tract morphogenesis | GO:0003253 | 3 | 0.051 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.051 | |
| respiratory system development | GO:0060541 | 190 | 0.051 | |
| heart valve morphogenesis | GO:0003179 | 21 | 0.051 | |
| positive regulation of gliogenesis | GO:0014015 | 27 | 0.051 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.051 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.050 | |
| commitment of multipotent stem cells to neuronal lineage in forebrain | GO:0021898 | 3 | 0.050 | |
| t cell differentiation | GO:0030217 | 174 | 0.050 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.050 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.050 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.050 | |
| appendage development | GO:0048736 | 166 | 0.050 | |
| ventricular zone neuroblast division | GO:0021847 | 3 | 0.050 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.050 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.050 | |
| organelle assembly | GO:0070925 | 177 | 0.050 | |
| cardiac chamber development | GO:0003205 | 108 | 0.050 | |
| medulla oblongata development | GO:0021550 | 3 | 0.050 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.050 | |
| positive regulation of secondary heart field cardioblast proliferation | GO:0072513 | 4 | 0.049 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.049 | |
| cation homeostasis | GO:0055080 | 212 | 0.049 | |
| endodermal cell fate commitment | GO:0001711 | 12 | 0.049 | |
| detection of external stimulus | GO:0009581 | 61 | 0.049 | |
| tricuspid valve development | GO:0003175 | 3 | 0.049 | |
| blastocyst development | GO:0001824 | 80 | 0.049 | |
| multicellular organism growth | GO:0035264 | 161 | 0.049 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.048 | |
| replacement ossification | GO:0036075 | 26 | 0.048 | |
| locomotory behavior | GO:0007626 | 195 | 0.048 | |
| tangential migration from the subventricular zone to the olfactory bulb | GO:0022028 | 5 | 0.048 | |
| melanocyte migration | GO:0097324 | 2 | 0.048 | |
| bundle of his development | GO:0003166 | 4 | 0.048 | |
| chromatin organization | GO:0006325 | 206 | 0.048 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.048 | |
| glial cell development | GO:0021782 | 54 | 0.047 | |
| oxidation reduction process | GO:0055114 | 342 | 0.047 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.047 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.047 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.047 | |
| cell division | GO:0051301 | 120 | 0.047 | |
| placenta development | GO:0001890 | 140 | 0.047 | |
| camera type eye development | GO:0043010 | 266 | 0.047 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.047 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.046 | |
| artery development | GO:0060840 | 53 | 0.046 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.046 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.046 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.046 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.046 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.046 | |
| response to hypoxia | GO:0001666 | 58 | 0.046 | |
| neural plate development | GO:0001840 | 12 | 0.045 | |
| cartilage morphogenesis | GO:0060536 | 11 | 0.045 | |
| regulation of cardiac chamber morphogenesis | GO:1901219 | 2 | 0.044 | |
| ear morphogenesis | GO:0042471 | 118 | 0.044 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.044 | |
| endocrine pancreas development | GO:0031018 | 29 | 0.044 | |
| telencephalon regionalization | GO:0021978 | 14 | 0.044 | |
| positive regulation of branching involved in lung morphogenesis | GO:0061047 | 4 | 0.044 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.043 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.043 | |
| face morphogenesis | GO:0060325 | 29 | 0.043 | |
| positive regulation of hh target transcription factor activity | GO:0007228 | 3 | 0.043 | |
| hormone metabolic process | GO:0042445 | 86 | 0.043 | |
| glomerulus morphogenesis | GO:0072102 | 10 | 0.043 | |
| inner ear receptor cell differentiation | GO:0060113 | 61 | 0.043 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.043 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.043 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.043 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.042 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.042 | |
| cardiac muscle cell proliferation | GO:0060038 | 31 | 0.042 | |
| his purkinje system development | GO:0003164 | 4 | 0.042 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.042 | |
| regulation of gastrulation | GO:0010470 | 16 | 0.042 | |
| neural tube patterning | GO:0021532 | 43 | 0.042 | |
| dichotomous subdivision of terminal units involved in ureteric bud branching | GO:0060678 | 1 | 0.042 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.042 | |
| metencephalon development | GO:0022037 | 89 | 0.042 | |
| negative regulation of apoptotic process involved in outflow tract morphogenesis | GO:1902257 | 2 | 0.042 | |
| renal system vasculature development | GO:0061437 | 15 | 0.042 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.041 | |
| spinal cord oligodendrocyte cell differentiation | GO:0021529 | 3 | 0.041 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.041 | |
| positive regulation of epithelial to mesenchymal transition | GO:0010718 | 13 | 0.041 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.041 | |
| cartilage development | GO:0051216 | 140 | 0.041 | |
| axial mesodermal cell fate specification | GO:0048327 | 1 | 0.040 | |
| negative regulation of heart looping | GO:1901208 | 1 | 0.040 | |
| protein acylation | GO:0043543 | 64 | 0.040 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.040 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.040 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.040 | |
| smoothened signaling pathway involved in ventral spinal cord patterning | GO:0021910 | 7 | 0.040 | |
| blood coagulation | GO:0007596 | 76 | 0.040 | |
| cellular homeostasis | GO:0019725 | 240 | 0.039 | |
| negative regulation of glial cell differentiation | GO:0045686 | 21 | 0.039 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.039 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.039 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.039 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.039 | |
| negative regulation of transcription from rna polymerase ii promoter by glucose | GO:0000433 | 1 | 0.039 | |
| metanephric capsule formation | GO:0072266 | 1 | 0.039 | |
| pulmonary valve formation | GO:0003193 | 1 | 0.039 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.039 | |
| negative regulation of synapse maturation | GO:2000297 | 2 | 0.039 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 33 | 0.039 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.039 | |
| cardiac septum development | GO:0003279 | 59 | 0.039 | |
| atrioventricular bundle cell differentiation | GO:0003167 | 1 | 0.039 | |
| regulation of system process | GO:0044057 | 200 | 0.039 | |
| renal sodium excretion | GO:0035812 | 3 | 0.039 | |
| smoothened signaling pathway involved in dorsal ventral neural tube patterning | GO:0060831 | 12 | 0.039 | |
| ureteric bud development | GO:0001657 | 94 | 0.038 | |
| regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | GO:2000148 | 1 | 0.038 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.038 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.038 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.038 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.038 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.038 | |
| positive regulation of transcription via serum response element binding | GO:0010735 | 1 | 0.038 | |
| metanephric nephron tubule formation | GO:0072289 | 4 | 0.038 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.038 | |
| response to inorganic substance | GO:0010035 | 96 | 0.038 | |
| positive regulation of monocyte chemotaxis | GO:0090026 | 2 | 0.038 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.037 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.037 | |
| regulation of transcription involved in primary germ layer cell fate commitment | GO:0060796 | 2 | 0.037 | |
| positive regulation of striated muscle cell differentiation | GO:0051155 | 35 | 0.037 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.037 | |
| tongue muscle cell differentiation | GO:0035981 | 2 | 0.037 | |
| neuron projection extension involved in neuron projection guidance | GO:1902284 | 14 | 0.037 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.037 | |
| forebrain radial glial cell differentiation | GO:0021861 | 4 | 0.037 | |
| heart trabecula morphogenesis | GO:0061384 | 26 | 0.037 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.036 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.036 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.036 | |
| regulation of defense response | GO:0031347 | 233 | 0.036 | |
| limb morphogenesis | GO:0035108 | 149 | 0.036 | |
| ossification | GO:0001503 | 216 | 0.036 | |
| regulation of cell growth | GO:0001558 | 91 | 0.036 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.036 | |
| nephron development | GO:0072006 | 109 | 0.036 | |
| autonomic nervous system development | GO:0048483 | 43 | 0.036 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.035 | |
| cardiac endothelial cell differentiation | GO:0003348 | 4 | 0.035 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.035 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.035 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.035 | |
| coronary vasculature development | GO:0060976 | 12 | 0.035 | |
| male gonad development | GO:0008584 | 88 | 0.035 | |
| mesenchymal cell proliferation involved in ureter development | GO:0072198 | 4 | 0.035 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.035 | |
| regulation of heart morphogenesis | GO:2000826 | 22 | 0.035 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.035 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.035 | |
| carbohydrate transport | GO:0008643 | 62 | 0.035 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.035 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.035 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.035 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.034 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.034 | |
| closure of optic fissure | GO:0061386 | 2 | 0.034 | |
| specification of organ position | GO:0010159 | 3 | 0.034 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.034 | |
| left lung development | GO:0060459 | 4 | 0.034 | |
| negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | GO:2000166 | 1 | 0.034 | |
| blood circulation | GO:0008015 | 195 | 0.034 | |
| regulation of cell activation | GO:0050865 | 289 | 0.034 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.034 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.034 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.034 | |
| striated muscle hypertrophy | GO:0014897 | 24 | 0.034 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.033 | |
| protein import into nucleus | GO:0006606 | 95 | 0.033 | |
